SIM
BSX icon

Sentry Investment Management’s Boston Scientific BSX Stock Holding History

Sentry Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,250
Closed -$405K – 72
2025
Q4 		$405K Hold
4,250
– – 0.27% 74
2025
Q3 		$411K Sell
4,250
-443
-9% -$45.9K 0.27% 67
2025
Q2 		$481K Hold
4,693
– – 0.27% 72
2025
Q1 		$430K Sell
4,693
-1,402
-23% -$141K 0.29% 65
2024
Q4 		$544K Sell
6,095
-992
-14% -$87.3K 0.26% 83
2024
Q3 		$594K Hold
7,087
– – 0.25% 89
2024
Q2 		$546K Sell
7,087
-592
-8% -$43.3K 0.24% 95
2024
Q1 		$526K Hold
7,679
– – 0.2% 119
2023
Q4 		$444K Sell
7,679
-825
-10% -$44K 0.19% 134
2023
Q3 		$449K Sell
8,504
-1,623
-16% -$85.1K 0.22% 99
2023
Q2 		$548K Buy
10,127
+676
+7% +$35.3K 0.21% 120
2023
Q1 		$473K Sell
9,451
-644
-6% -$30.4K 0.19% 134
2022
Q4 		$467K Buy
10,095
+524
+5% +$22.7K 0.21% 125
2022
Q3 		$371K Hold
9,571
– – 0.18% 125
2022
Q2 		$357K Sell
9,571
-1,864
-16% -$75.9K 0.16% 135
2022
Q1 		$506K Sell
11,435
-2,354
-17% -$102K 0.16% 130
2021
Q4 		$586K Buy
13,789
+851
+7% +$35.8K 0.15% 152
2021
Q3 		$561K Sell
12,938
-1,890
-13% -$83.6K 0.16% 147
2021
Q2 		$634K Hold
14,828
– – 0.16% 148
2021
Q1 		$573K Sell
14,828
-75,444
-84% -$2.86M 0.16% 152
2020
Q4 		$3.25M Hold
90,272
– – 0.16% 149
2020
Q3 		$3.45M Buy
90,272
+5,043
+6% +$194K 0.19% 130
2020
Q2 		$2.99M Buy
85,229
+269
+0.3% +$9.69K 0.18% 139
2020
Q1 		$2.77M Hold
84,960
– – 0.2% 120
2019
Q4 		$3.84M Hold
84,960
– – 0.23% 117
2019
Q3 		$3.46M Hold
84,960
– – 0.23% 119
2019
Q2 		$3.65M Buy
84,960
+4,214
+5% +$162K 0.24% 110
2019
Q1 		$3.1M Sell
80,746
-7,169
-8% -$274K 0.21% 118
2018
Q4 		$3.11M Sell
87,915
-2,309
-3% -$83.7K 0.23% 115
2018
Q3 		$3.47M Hold
90,224
– – 0.21% 125
2018
Q2 		$2.95M Sell
90,224
-7,609
-8% -$229K 0.19% 142
2018
Q1 		$2.67M Sell
97,833
-9,410
-9% -$256K 0.16% 164
2017
Q4 		$2.66M Hold
107,243
– – 0.15% 177
2017
Q3 		$3.13M Hold
107,243
– – 0.12% 152
2017
Q2 		$2.97M Buy
107,243
+1,125
+1% +$29.9K 0.12% 149
2017
Q1 		$2.64M Buy
106,118
+903
+0.9% +$22K 0.11% 156
2016
Q4 		$2.28M Hold
105,215
– – 0.1% 180
2016
Q3 		$2.5M Buy
105,215
+4,189
+4% +$99.9K 0.11% 164
2016
Q2 		$2.36M Hold
101,026
– – 0.1% 157
2016
Q1 		$1.9M Hold
101,026
– – 0.09% 183
2015
Q4 		$1.86M Buy
101,026
+7,579
+8% +$136K 0.09% 192
2015
Q3 		$1.53M Hold
93,447
– – 0.08% 196
2015
Q2 		$1.65M Buy
93,447
+3,450
+4% +$61.7K 0.08% 205
2015
Q1 		$1.6M Buy
89,997
+29,700
+49% +$469K 0.08% 197
2014
Q4 		$799K Hold
60,297
– – 0.04% 301
2014
Q3 		$712K Sell
60,297
-7,435
-11% -$93.6K 0.04% 310
2014
Q2 		$865K Sell
67,732
-4,968
-7% -$64.6K 0.04% 293
2014
Q1 		$983K Hold
72,700
– – 0.05% 254
2013
Q4 		$874K Buy
72,700
+52,900
+267% +$625K 0.05% 278
2013
Q3 		$232K Buy
+19,800
New +$214K 0.01% 498

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sentry Investment Management's BSX Position: Q1 2026 in Review

Sentry Investment Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,250 shares — an estimated $405K sold.

Sentry Investment Management first reported a position in BSX in Q3 2013 and held it in 50 quarters. The position peaked at $3.84M in Q4 2019. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Sentry Investment Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 4,250 Boston Scientific shares in Q1 2026, an estimated $405K.
  • Sentry Investment Management first reported a position in Boston Scientific in Q3 2013 and held it in 50 quarters.
  • Sentry Investment Management's Boston Scientific position peaked at $3.84M in Q4 2019.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.